Soumya Shraddhya Paul, Amity University, Noida The extent to which Covid vaccinations can protect people who have organ transplants is yet unknown. Transplantation doctors have long feared that the Covid vaccinations aren’t providing enough protection to patients undergoing transplants. Few studies have suggested that even after being completely vaccinated with mRNA vaccines, which are believed […]
Akash Singh, Banaras Hindu University COVID-19 vaccines based on messenger RNA (mRNA) were recently approved to be used in an emergency. The World Health Organization (WHO) made a statement to increase awareness regarding breastfeeding after getting vaccinated and advised not to cessate breastfeeding following vaccine administration. Still, many mothers have discontinued breastfeeding due to concern […]
Saptaparna Dasgupta, Bennett University A recently published new study states that both the Pfizer-BioNTech and Moderna COVID-19 vaccine immune system reactions have proved to offer long-lasting protection against COVID-19. mRNA vaccines have created more and better germinal centre B cell responses, thus indicating that the immunity system would be much more impactful and offer long-lasting […]
Sayan Roy, Pondicherry University mRNA-1273 is a messenger RNA (mRNA) vaccine, designed to fight against Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2). It is developed by a US-based pharmaceutical company- Moderna, in association with NIAID Vaccine Research Center. The mRNA-1273 vaccine encodes for the SARS-CoV-2 full-length spike glycoprotein trimer ‘S-2P’, but modified to incorporate two proline substitutions […]
Avipsha Datta, Department of Biophysics and Molecular Biology, University of Calcutta Covid-19 Vaccine- the one thing we are very much hoping for right now! Well, here is some news update that might give us a little more hope. The Drugmaker Company Moderna has announced that it is preparing to launch its potential Coronavirus vaccine mRNA-1273.Meanwhile, […]
Ayushman Kumar Banerjee With over 43 million COVID-19 cases having surfaced and more than 1.1 million deaths, researchers are relentlessly working round the clock to develop vaccines against the virus, SARS-CoV-2, which causes the COVID-19. This has led to a race for a vaccine against the novel coronavirus, and in this race, Moderna has devised […]
Chitra Roy, University of Calcutta An American biotechnology company ‘Moderna’, based in Cambridge, Massachusetts focuses on the discovery and development of drugs in addition to vaccine technologies. They exclusively use messenger RNA (mRNA) therapeutics and designs vaccines to create a completely new generation of transformative medicines. Against COVID-19, Moderna has developed its mRNA vaccine candidate […]
Ayooshi Mitra, Amity University Kolkata To avert the spread of the pandemic of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), a successful vaccine is needed. In an examination directed recently, safety, tolerability, and neutralizer reaction information from an on-going placebo-controlled treatment observer-blinded phase 1/2 coronavirus disease 2019 (COVID-19) vaccine trial BNT162b1, a lipid nanoparticle (LNP) nucleoside-modified […]
